NIH, FDA, 15 Orgs Boost Gene Therapy Development for Rare Diseases
FDA Accepts Application for Novartis’ Diabetic Macular Edema Drug
New Pilot to Leverage API, AI for Enhanced Diagnostic Accuracy
Bristol Myers Squibb Reinforces Efficacy of MS Drug, Zeposia
FDA Approves Eli Lilly and Company’s Breast Cancer Treatment
Cerner Leverages Real-World Evidence to Advance Therapies
Two Doses of Moderna’s COVID-19 Vaccine Effective in Children
FDA Approves Expansion of Gilead’s HIV Drug in Pediatric Patients
Pfizer, BioNTech COVID-19 Vaccine Booster Dose 95.6% Effective
CDC Unanimously Recommends J&J, Moderna COVID-19 Vaccine Booster
CVS Health Says Pharmacists Key for Medication Adherence, Access
FDA Authorizes Moderna, J&J Booster COVID-19 Vaccine Dose
FDA Approves Interchangeable Biosimilar for Inflammatory Diseases
FDA Approves First Treatment for Rare Disease Congenital Athymia
FDA Awards $25M in Grants to Clinical Trials Studying Rare Diseases
FDA Recommends Booster Dose of Moderna’s COVID-19 Vaccine
FDA Recommends Authorization For J&J’s COVID-19 Vaccine Booster
Roche Receives Breakthrough Therapy for Alzheimer’s Disease
AstraZeneca’s COVID-19 Antibody Prevents and Treats COVID-19
Merck Enters Into $11.5B Deal to Boost Cardiovascular Pipeline
WHO Recommends Broad Roll-Out of GSK’s Malaria Vaccine For Children
Moderna to Build State-of-the-Art mRNA Facility in Africa
J&J’s Early-Stage Compound Shows Promise Against Dengue Virus
FDA Grants Designation For Daiichi Sankyo’s Breast Cancer Treatment
J&J’s Chief Scientific Officer Paul Stoffels Announces Retirement
ViiV Healthcare Submits FDA Application for HIV Regimen
AstraZeneca Acquires Caelum Biosciences For Rare Disease Antibody
Marketing Strategies to Boost Access to Prescription Medications
J&J Submits Data to FDA to Support COVID-19 Vaccine Booster
FDA Approves Kite’s CAR T-Cell Therapy For Leukemia
Johnson & Johnson Launches Phase 3 Trial of RSV Vaccine in Adults
FDA Approves Amgen’s Repatha for Autosomal Dominant Disease
AstraZeneca Requests FDA EUA for COVID-19 Antibody Combination
Francis Collins Resigns as Director of the NIH After 12 Years
J&J’s Xarelto Evokes Fewer Blood Clots in Patients Than Aspirin
Regeneron’s COVID-19 Antibody Cocktail Helps Hospitalized Patients
Pfizer Submits Data to FDA For COVID-19 Vaccine in Children